Sage Therapeutics (SAGE) PT Raised to $123 at Leerink Partners
Tweet
Share
E-mail
Get Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
Leerink Partners analyst Paul Matteis raised its price target on Sage Therapeutics (NASDAQ: SAGE) to $123.00 (from $85.00) while maintaining an Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macquarie Downgrades Mercari, Inc (4385:JP) (MRCIF) to Neutral
- JPMorgan Downgrades Arafura Rare Earths (ARU:AU) to Underweight
- MS&AD Insurance Group Holdings, Inc (8725:JP) (MSADY) PT Raised to JPY5,200 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
